|
|
||||||||
1 Departments of Biochemistry and Ophthalmology, Northwestern University Medical School, Chicago, Ill.
The topical application of reserpine and the benzoquinolizine Ro 4-1284 to rabbit eyes leads to a significant depression of the intraocular pressure. This reduction is due essentially to a depression of the formation rate and is counteracted by a small drop in facility of outflow. As in other biologic systems, the action of reserpine lasts longer and requires lower concentrations than that of the benzoquinolizine. Bradykinin, which is also capable of releasing amines, acts quite differently from these two agents by increasing the facility of outflow of the rabbit eye. Similarly, the rate of outflow in the excised bovine eye is enhanced markedly by this nonapeptide. The combined effects of the monoamine oxidase inhibitor (MAO) pargyline and the releasing agents depend a great deal on the sequence of drug application. When reserpine and pargyline are administered together for several days, extremely low values for the formation rate are observed. In most other combinations, the releasers cancel the action of the MAO inhibitor and vice versa. This indicates that, although the actions of reserpine or pargyline alone on the aqueous humor dynamics are quite similar, their mechanisms of action must be profoundly different. The phenomena cannot he interpreted alone in terms of changes of norepinephrine levels in the ciliary body.
Note:
Presented in part at the National Association for Research in Ophthalmology Meeting, Tampa, Fla., May 1, 1968,1 at the Central Mississippi Section Meeting of the Association for Re-search in Ophthalmology, Indianapolis, Ind., April 3, 1970,2 and at the National Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fla., May 3, 1970.
Key Words: reserpine benzoquinolizine Ro 4-1284 bradykinin pargyline tonography seasonal variations of tonographic parameters
Submitted on November 17, 1970
Accepted on February 8, 1971
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |